This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego
Register Now
Menu
Book Now

Joo-Sung Yang, PhD
Senior VP, Head of mRNA R&BD and Head of Biotechnology R&D at ST Pharm

Profile

Expert in gene therapy, genetic vaccine design and development in the area of infectious diseases & cancer immunotherapy

Diverse experiences with about 30 years of academy and industry in viral immunology, biotechnology, gene therapy, vaccines (conventional, subunit, recombinant viral vectors, DNA & mRNA, edible etc.), and oligonucleotide therapeutics.

DNA-based gene optimization knowhow and platform patent holding for potent immunogens creation

Agenda Sessions

  • A Capping Library Screening System of SmartCap® Facilitates Identification and Selection the Most Efficient Capping Analog in mRNA Drug Development

    , 12:20pm
    View Session

Speakers at this event

Prev
Next
Ed Yaworski
Chief Technology Officer
Genevant Sciences Corp.

See Joo-Sung Speak

Register Now